122 related articles for article (PubMed ID: 28288903)
1. Silencing of hTERT blocks growth and migration of anaplastic thyroid cancer cells.
Maggisano V; Celano M; Lombardo GE; Lepore SM; Sponziello M; Rosignolo F; Verrienti A; Baldan F; Puxeddu E; Durante C; Filetti S; Damante G; Russo D; Bulotta S
Mol Cell Endocrinol; 2017 Jun; 448():34-40. PubMed ID: 28288903
[TBL] [Abstract][Full Text] [Related]
2. Anti-
Lombardo GE; Maggisano V; Celano M; Cosco D; Mignogna C; Baldan F; Lepore SM; Allegri L; Moretti S; Durante C; Damante G; Fresta M; Russo D; Bulotta S; Puxeddu E
Mol Cancer Ther; 2018 Jun; 17(6):1187-1195. PubMed ID: 29563163
[TBL] [Abstract][Full Text] [Related]
3. Quantitative measurement of telomerase reverse transcriptase, thyroglobulin and thyroid transcription factor 1 mRNAs in anaplastic thyroid carcinoma tissues and cell lines.
Takano T; Ito Y; Matsuzuka F; Miya A; Kobayashi K; Yoshida H; Miyauchi A
Oncol Rep; 2007 Sep; 18(3):715-20. PubMed ID: 17671725
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of S100A4 blocks growth and metastasis of anaplastic thyroid cancer cells in vitro and in vivo.
Zhang K; Yu M; Hao F; Dong A; Chen D
Cancer Biomark; 2016 Sep; 17(3):281-291. PubMed ID: 27802204
[TBL] [Abstract][Full Text] [Related]
5. Effect of Slug-Mediated Down-Regulation of E-Cadherin on Invasiveness and Metastasis of Anaplastic Thyroid Cancer Cells.
Sheng L; Zhang S; Xu H
Med Sci Monit; 2017 Jan; 23():138-143. PubMed ID: 28070118
[TBL] [Abstract][Full Text] [Related]
6. Targeted inhibition of long non-coding RNA H19 blocks anaplastic thyroid carcinoma growth and metastasis.
Zhang H; Yu Y; Zhang K; Liu X; Dai Y; Jiao X
Bioengineered; 2019 Dec; 10(1):306-315. PubMed ID: 31299871
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of hTERT and concurrent treatment with interferon-gamma inhibited proliferation and invasion of human glioblastoma cell lines.
George J; Banik NL; Ray SK
Int J Biochem Cell Biol; 2010 Jul; 42(7):1164-73. PubMed ID: 20394835
[TBL] [Abstract][Full Text] [Related]
8. hTERT-targeted RNA interference inhibits tumorigenicity and motility of HCT116 cells.
Shen Y; Zhang YW; Zhang ZX; Miao ZH; Ding J
Cancer Biol Ther; 2008 Feb; 7(2):228-36. PubMed ID: 18059183
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines.
Mitomo S; Maesawa C; Ogasawara S; Iwaya T; Shibazaki M; Yashima-Abo A; Kotani K; Oikawa H; Sakurai E; Izutsu N; Kato K; Komatsu H; Ikeda K; Wakabayashi G; Masuda T
Cancer Sci; 2008 Feb; 99(2):280-6. PubMed ID: 18201269
[TBL] [Abstract][Full Text] [Related]
10. Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.
Chen R; Zhu J; Dong Y; He C; Hu X
Oncotarget; 2015 Oct; 6(32):32841-55. PubMed ID: 26418880
[TBL] [Abstract][Full Text] [Related]
11. Lentiviral vector mediated siRNA knock-down of hTERT results in diminished capacity in invasiveness and in vivo growth of human glioma cells in a telomere length-independent manner.
Zhao P; Wang C; Fu Z; You Y; Cheng Y; Lu X; Lu A; Liu N; Pu P; Kang C; Salford LG; Fan X
Int J Oncol; 2007 Aug; 31(2):361-8. PubMed ID: 17611693
[TBL] [Abstract][Full Text] [Related]
12. Long-term suppression of telomerase expression in HeLa cell clones, transfected with an expression vector carrying siRNA targeting hTERT mRNA.
Kurvinen K; Syrjänen S; Johansson B
Int J Oncol; 2006 Jul; 29(1):279-88. PubMed ID: 16773210
[TBL] [Abstract][Full Text] [Related]
13. MiR-661 inhibits glioma cell proliferation, migration and invasion by targeting hTERT.
Li Z; Liu YH; Diao HY; Ma J; Yao YL
Biochem Biophys Res Commun; 2015 Dec; 468(4):870-6. PubMed ID: 26585488
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of hTERT by siRNA inhibits cervical cancer cell growth in vitro and in vivo.
Shi YA; Zhao Q; Zhang LH; Du W; Wang XY; He X; Wu S; Li YL
Int J Oncol; 2014 Sep; 45(3):1216-24. PubMed ID: 24920549
[TBL] [Abstract][Full Text] [Related]
15. Keratin 23 promotes telomerase reverse transcriptase expression and human colorectal cancer growth.
Zhang N; Zhang R; Zou K; Yu W; Guo W; Gao Y; Li J; Li M; Tai Y; Huang W; Song C; Deng W; Cui X
Cell Death Dis; 2017 Jul; 8(7):e2961. PubMed ID: 28749462
[TBL] [Abstract][Full Text] [Related]
16. Small interfering RNA (siRNA) against Slug induces apoptosis and sensitizes human anaplastic thyroid carcinoma cells to doxorubicin.
Pan Y; Liu P; Chen D; Dou L
Cancer Biomark; 2017; 18(4):357-366. PubMed ID: 28128736
[TBL] [Abstract][Full Text] [Related]
17. [Inhibitory effect of silencing hTERT gene on growth of human squamous cell carcinoma xenograft in nude mice].
Yao X; Wang X; Zhang S; Yan L; Zhu H
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Oct; 25(20):939-43. PubMed ID: 22239057
[TBL] [Abstract][Full Text] [Related]
18. Telomerase activity and expression of the telomerase catalytic subunit, hTERT, in meningioma progression.
Simon M; Park TW; Leuenroth S; Hans VH; Löning T; Schramm J
J Neurosurg; 2000 May; 92(5):832-40. PubMed ID: 10794298
[TBL] [Abstract][Full Text] [Related]
19. MiR-125b inhibits anaplastic thyroid cancer cell migration and invasion by targeting PIK3CD.
Bu Q; You F; Pan G; Yuan Q; Cui T; Hao L; Zhang J
Biomed Pharmacother; 2017 Apr; 88():443-448. PubMed ID: 28122310
[TBL] [Abstract][Full Text] [Related]
20. The Role of Notch1 Signaling in Anaplastic Thyroid Carcinoma.
Kim HJ; Kim MJ; Kim A; Jung CW; Park S; Koh JS; Myung JK
Cancer Res Treat; 2017 Apr; 49(2):509-517. PubMed ID: 27586674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
